Concepedia

Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron

Alan S. Coates, Annabel Childs, Katherine Cox, Cecily Forsyth, D.F. Joshua, Edward McNeil, John J. Grygiel

Annals of Oncology · 1992 · 15 citations · 13 references

DOIFull text

Open access

Concepts

References

13

TROUSSEAUʼS SYNDROME AND OTHER MANIFESTATIONS OF CHRONIC DISSEMINATED COAGULOPATHY IN PATIENTS WITH NEOPLASMS

George H. Sack, Jack Levin, William R. Bell · Medicine · 1977 · 573 citations

, , +9

Comparison of the 5-Hydroxytryptamine<sub>3</sub>(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis

Michel Marty, P Pouillart, Jean Pierre Droz et al. · New England Journal of Medicine · 1990 · 411 citations

, , +17

High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.

Catherine Patte, Thierry Philip, C Rodary et al. · Journal of Clinical Oncology · 1991 · 296 citations

, , +16

Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.

Fausto Roila, Maurizio Tonato, Francesco Cognetti et al. · Journal of Clinical Oncology · 1991 · 278 citations

, , +14

Acute Vascular Ischemic Events After Cisplatin-Based Combination Chemotherapy for Germ-Cell Tumors of the Testis

Donald C. Doll · Annals of Internal Medicine · 1986 · 225 citations

, , +15